Skip to main content

Post-market evaluation of serology-based point of care tests

In response to the COVID-19 pandemic, the TGA has expedited the approval (with conditions) of COVID-19 tests including tests intended for laboratory use and those intended for use by specified health professionals at the point of care.

Last updated

Help us improve the Therapeutic Goods Administration site